NYSE

Klaviyo, Inc. Series A (KVYO)

400 Thanks from members

Klaviyo, Inc. Series A (KVYO) demonstrates solid operational performance, highlighted by a Q1 2026 EPS beat of $0.22 (surpassing estimates by 10.22%), while technical indicators show strong price support near $15.05 alongside occasional sessions of minor downward consolidation.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →